Dolutegravir Plus Lamivudine Simplified Therapy — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Dolutegravir Plus Lamivudine Simplified Therapy — Stella

Recruiting

Back to HIV/AIDS trials

Trial locations(1 site)

China

Guangzhou 8th People's Hospital, Guangzhou, Guangdong

Key details

Sponsor

Guangzhou 8th People's Hospital

Collaborators

Shenzhen Third People's Hospital, Dongguan People's Hospital

Enrollment target

~300 participants

Started

January 2019

Primary completion

December 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated September 2022

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov